Stockholders' Equity - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands |
Oct. 07, 2025 |
Jan. 22, 2024 |
Mar. 31, 2026 |
Dec. 31, 2025 |
Aug. 31, 2022 |
|---|---|---|---|---|---|
| Class Of Stock [Line Items] | |||||
| Common Stock, Shares Subscribed but Unissued | 4,375,062 | 2,023,729 | |||
| Common stock, shares issued | 332,812 | 9,597,693 | 9,586,770 | ||
| Common stock, shares authorized | 300,000,000 | 300,000,000 | |||
| Underwriting discounts and commissions and other offering expenses | $ 74,800 | $ 91,700 | |||
| Sale of Stock, Price Per Share | $ 16 | ||||
| Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 38.3984 | ||||
| Exercise of warrant, shares | 625,000 | 527,833 | |||
| Dividends Payable | $ 0 | ||||
| Common stock shares issued, par value | $ 0.0016 | $ 0.0016 | $ 0.0001 | $ 0.0001 | |
| 2021 Sales Agreement | |||||
| Class Of Stock [Line Items] | |||||
| Sale of Stock, Price Per Share | $ 275.68 | ||||
| Common stock shares issued, par value | $ 0.0001 | ||||
| 2025 Pre-Funded Warrants | |||||
| Class Of Stock [Line Items] | |||||
| Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 15.9984 |
| X | ||||||||||
- Definition Stock issued during period shares warrant exercised. No definition available.
|
| X | ||||||||||
- Definition Underwriting discounts and commissions and other offering expenses. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|